A. Papi (Ferrara, Italy), H. Lode (Berlin, Germany)
CD4+ T cell responses to non-encapsulated Haemophilus influenzae in patients with chronic obstructive pulmonary disease
G. J. de Bree, R. E. Jonkers, H. Korse, R. A. van Lier, H. M. Jansen, T. A. Out (Amsterdam, The Netherlands)
|  |
Chlamydia pneumoniae persists in TLR2 positive alveolar epithelial cells type II and alveolar macrophages of COPD patients
D. Droemann, T. Goldmann, J. Rupp, M. Maass, D. Branscheid, E. Vollmer, P. Zabel, K. Dalhoff (Borstel, Luebeck, Grosshansdorf, Germany)
| |
Demonstration of chlamydia species in induced sputum from COPD patients by nested PCR and immunofluorescence
O. Anhenn, G. Rohde, H. Hotzel, K. Sachse, J. M. Mertens, D. Theegarten (Bochum, Jena, Germany)
| |
Serologic markers for Chlamydia pneumoniae in acute exacerbation of COPD or asthma
F. Vincent, J. Petitjean, A. Vabret, J. Brun, F. Freymuth (Limoges, Caen, France)
| |
Sputum colour as a marker of acute bacterial exacerbations of COPD
L. Allegra, G. Beghi, P. Diano, P. Tarsia, S. Galbiati, R. Cosentini, F. Blasi (Milan, Italy)
|  |
Short-term efficacy of moxifloxacin (MXF) compared to standard antibiotic treatment (STD) in acute exacerbations of chronic bronchitis (AECB): A multivariate analysis from the MOSAIC study
R. Wilson, L. Allegra, G. Huchon, J. L. Izquierdo, P. Jones, T. Schaberg, P. Arvis, I. Duprat-Lomon, N. Liyanage, P. P. Sagnier (London, Stoke Poges, United Kingdom; Milan, Italy; Paris, Puteaux, France; Guadalajara, Spain; Rotenburg, Germany)
| |
Five-day telithromycin is as effective as 10-day clarithromycin in the treatment of acute exacerbations of chronic bronchitis
C. Fogarty, R. de Wet, R. Nusrat (Spartanburg, Bridgewater, United States Of America; Johannesburg, South Africa)
| |
Microbiological and inflammatory patterns in severe exacerbated COPD
B. Lara, N. Soler, A. Carles, F. Xavier, B. Joan Ramon, F. Miquel, M. Marc, T. Antoni (Barcelona, Spain)
| |